these and other findings are a starting point for planning a therapy of beta-thalassemia by means of gene technology : correction of the defect within the abnormal beta-globin gene , replacement of the beta-globin gene , stimulation of gamma-globin synthesis .
C0005221
beta-globin
C0017033
gamma-globin